Amanote Research
Register
Sign In
Serum Cystatin C Is a Better Marker of Topotecan Clearance Than Serum Creatinine
Clinical Cancer Research
- United States
doi 10.1158/1078-0432.ccr-04-2086
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
April 15, 2005
Authors
A. Hoppe
Publisher
American Association for Cancer Research (AACR)
Related search
Serum Cystatin C Compared to Serum Creatinine as an Early Marker of Renal Failure
International Journal of Current Microbiology and Applied Sciences
Two-Hour Creatinine Clearance and Glomerular Filtration Rate Estimated From Serum Cystatin C and Creatinine in the Elderly to Preoperative Period
Open Journal of Nephrology
Study of Serum Creatine Kinase Level, Cystatin C and Creatinine Level in Hypothyroidism
Scholars International Journal of Biochemistry
Is Serum Cystatin C the Marker of Choice to Predict Glomerular Filtration Rate in Paediatric Patients?
Annals of Clinical Biochemistry
Medicine
Clinical Biochemistry
Influence of Muscle Mass, Physical Activity and Nutritional Status on Serum Creatinine and Serum Cystatin C in Elderly Population
International Journal of Contemporary Medicine, Surgery and Radiology
Estimation of Glomerular Filtration Rate From Serum Creatinine and Cystatin C in Octogenarians and Nonagenarians
BMC Nephrology
Nephrology
Serum Cystatin C: An Early Marker of Organ Damage in Patients With Arterial Hypertension
High Blood Pressure and Cardiovascular Prevention
Internal Medicine
Cardiovascular Medicine
Cardiology
Serum Amyloid-A Rather Than C-Reactive Protein Is a Better Predictor of Mortality in Hemodialysis Patients
Tohoku Journal of Experimental Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Serum Cystatin C– Versus Creatinine-Based Definitions of Acute Kidney Injury Following Cardiac Surgery: A Prospective Cohort Study
American Journal of Kidney Diseases
Nephrology
